The use of atypical antipsychotics after traumatic brain injury.
Elovic
Elie Paul
EP
Traumatic Brain Injury Research Laboratory, Kessler Medical Rehabilitation Research and Education Center, West Orange, NJ 07052, USA. eelovic@kmrrec.org
Jasey
Neil N
NN
Eisenberg
Michal E
ME
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications* / Q000534:rehabilitation; D003024:Clozapine / Q000627:therapeutic use; D003987:Dibenzothiazepines / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D011595:Psychomotor Agitation / Q000188:drug therapy; D000069348:Quetiapine Fumarate; D015363:Quinolones / Q000627:therapeutic use; D018967:Risperidone / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D010879:Piperazines; D015363:Quinolones; D013844:Thiazoles; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; C092292:ziprasidone; D000068180:Aripiprazole; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine